Oklahoma Objects To Stay Of $465M Opioid Judgment Against Johnson & Johnson

Mealey's (December 18, 2019, 8:48 AM EST) -- NORMAN, Okla. — The state of Oklahoma on Dec. 9 objected to a motion by defendants Johnson & Johnson and Janssen Pharmaceuticals to stay enforcement of a judge’s $465 million opioid abatement judgment and approval of a $25 million supersedeas bond pending appeal (Oklahoma, et al. v. Purdue Pharma L.P., et al., No. CJ-2017-816, Okla. Dist., Cleveland Co.)....

Attached Documents

Related Sections